The MM+M Podcast

Genentech isn’t currently developing a SARS-CoV-2 vaccine or therapeutic, but the biotech has been conducting research that could bring insight to bear on the willingness among communities of color to...

28 Loka 202026min

Deloitte's David Betts and Chris Zant join MM+M's Larry Dobrow to discuss the evolution in the way consultancies like Deloitte are working with life-sciences clients.

26 Loka 202036min

Bakul Patel, who has been leading regulatory and scientific efforts related to digital health devices at the FDA since 2010, speaks about the agency’s new Digital Health Center of Excellence, his goal...

13 Loka 202028min

Genevieve Paquette, chief development officer of medical gaming company Level Ex, joins MM+M's Larry Dobrow to discuss the state of the union for gamification efforts and the company's new COVID-speci...

7 Loka 202030min

Dan Trigub, former head of Uber Health who left on Sept. 8 to start his own healthcare company, returns to The MM+M Podcast to discuss his new firm, MedArrive, which is working to bring care into the ...

29 Syys 202030min

Tamar Thompson, VP of government affairs and policy at Alexion Pharmaceuticals, speaks with Marc Iskowitz about how the biotech company, which recently appointed its first chief diversity officer, has...

9 Syys 202038min

Salvatore Paolozza, Sr director, sales ops, Antares Pharma, speaks about ways he's leveraged technology to ensure Antares' reps maintain contact with doctors, as well as ways the firm is supporting HC...

1 Syys 202031min

John Kenyon, head of Meredith's Targeted Media Health unit, discusses the launch of People en Espanol Salud and the company's huge investment in the point-of-care space.

25 Elo 202044min